![Caitlin Pazzano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Caitlin Pazzano formerly worked at Flexion Therapeutics, Inc., as Vice President-Quality and Aldeyra Therapeutics, Inc., as Vice President-Quality Assurance from 2022 to 2024.
Ms. Pazzano received her undergraduate degree from the University of Massachusetts.
Ehemalige bekannte Positionen von Caitlin Pazzano
| Unternehmen | Position | Ende |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2024 |
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Caitlin Pazzano
University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALDEYRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
